Cell & Tissue Therapy 细胞及组织治疗
His interest in the complications of acute myocardial infarction drew him to investigating possible heart muscle regeneration through cell transplants tissue engineering and gene therapy.
他对急性心肌梗塞并发症的兴趣，引领他研究借由细胞移植、组织工程和基因疗法以促进心脏再生的可能性。
One option in future may be to create stem cells from a patient's own tissue, then return these after using gene therapy to correct the genetic mutation that causes sickle-cell disease.
未来一个选择是从患者的组织培养干细胞、经基因疗法纠正导致镰刀形细胞症的遗传变异后再移植给患者本身。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
应用推荐